Johnson & Johnson and Subsidiaries Condensed Consolidated Statement of Earnings (Unaudited; in Millions Except Per Share Figures) Percent Percent Percent Increase Amount to Sales Amount to Sales (Decrease) Sales to customers 20,691 $ 100.0 20,021 $ 100.0 3.3 Cost of products sold 7,062 34.1 6,615 33.0 6.8 Gross Profit 13,629 65.9 13,406 67.0 1.7 Selling, marketing and administrative expenses 5,203 25.1 5,219 26.1 (0.3) Research and development expense 2,580 12.5 2,858 14.3 (9.7) In-process research and development - - 890 4.4 Interest (income) expense, net (42) (0.2) 3 0.0 Other (income) expense, net (679) (3.3) (22) (0.1) Restructuring 58 0.3 36 0.2 Earnings before provision for taxes on income 6,509 31.5 4,422 22.1 47.2 Provision for taxes on income 713 3.5 673 3.4 5.9 Net earnings 5,796 28.0 3,749 18.7 54.6 Net earnings per share (Diluted) 2.17 $ 1.39 $ 56.1 Average shares outstanding (Diluted) 2,671.0 2,698.8 Effective tax rate 11.0 % 15.2 % Adjusted earnings before provision for taxes and net earnings (1) Earnings before provision for taxes on income 7,244 $ 35.0 6,867 $ 34.3 5.5 Net earnings 6,154 $ 29.7 5,661 $ 28.3 8.7 Net earnings per share (Diluted) 2.30 $ 2.10 $ 9.5 Effective tax rate 15.0 % 17.6 % (1) See Reconciliation of Non-GAAP Financial Measures. FIRST QUARTER 2020 2019 -- 1 of 1 --